SubscribeLatest 5 articles from heartwire
- Air pollutants mediate effects on heart health through inflammation and thrombosis
May 17, 2012 17:15 EDT - Statins benefit those at much lower CV risk
May 16, 2012 18:30 EDT - Azithromycin may up chance of sudden cardiac death
May 16, 2012 17:00 EDT - So long, Plavix, what a ride! Clopidogrel patent expires
May 16, 2012 14:45 EDT - COMFORTABLE-AMI: Bioerodable polymer DES trumps bare metal in STEMI
May 16, 2012 10:50 EDT
Archives
Should we prescribe novel anticoagulants or warfarin as first line agents for stroke prevention in AF?
4 Comments |
Posted May 06, 2012
at 01:25 PM, EDT by Samuel
at 01:25 PM, EDT by Samuel
Recent PE thrombolysis trials: MAPPET, MOPETT, and MUPPET, with Dr Stavros Konstantinides
No comments |
Posted Apr 27, 2012
at 11:55 AM, EDT by Samuel
at 11:55 AM, EDT by Samuel
The US Postal Service promotes heart health
No comments |
Posted Apr 20, 2012
at 01:50 PM, EDT by Samuel
at 01:50 PM, EDT by Samuel
Thrombolysis in acute pulmonary embolism: An update with Dr Stavros Konstantinides
No comments |
Posted Apr 04, 2012
at 03:08 PM, EDT by Samuel
at 03:08 PM, EDT by Samuel
Einstein PE: Rivaroxaban shines as viable monotherapy for pulmonary embolism
1 Comments |
Posted Mar 26, 2012
at 10:25 AM, EDT by Samuel
at 10:25 AM, EDT by Samuel
Methods to improve medication adherence
2 Comments |
Posted Mar 23, 2012
at 05:35 PM, EDT by Steven
at 05:35 PM, EDT by Steven
Henrietta Lacks and the HeLa cell (or how to profit from someone else's cancer cells)
6 Comments |
Posted Mar 16, 2012
at 09:30 AM, EDT by Samuel
at 09:30 AM, EDT by Samuel
Reducing risk of VTE with emotional well-being
No comments |
Posted Mar 09, 2012
at 10:30 AM, EDT by Samuel
at 10:30 AM, EDT by Samuel
INR testing in stable patients: Time to decrease frequency?
5 Comments |
Posted Mar 02, 2012
at 09:30 AM, EDT by Samuel
at 09:30 AM, EDT by Samuel
CHEST/ACCP 2012 guidelines: What's new?
3 Comments |
Posted Feb 24, 2012
at 07:45 AM, EDT by Samuel
at 07:45 AM, EDT by Samuel
RACE-2: Relaxing rate control in patients with permanent AF
No comments |
Posted Feb 17, 2012
at 09:30 AM, EDT by Samuel
at 09:30 AM, EDT by Samuel
Preventing postthrombotic syndrome: CAVENT supports the "open vein hypothesis"
3 Comments |
Posted Feb 10, 2012
at 09:20 AM, EDT by Samuel
at 09:20 AM, EDT by Samuel
IVC filters: The genie's out of the bottle
No comments |
Posted Feb 03, 2012
at 08:30 AM, EDT by Samuel
at 08:30 AM, EDT by Samuel
Emergency hospitalization from adverse drug events: Warfarin the biggest culprit
No comments |
Posted Jan 27, 2012
at 08:50 AM, EDT by Samuel
at 08:50 AM, EDT by Samuel
Self-monitoring INR and self-managing warfarin to reduce thromboembolic events
5 Comments |
Posted Jan 20, 2012
at 07:30 AM, EDT by Samuel
at 07:30 AM, EDT by Samuel
Also from theheart.org
Blogs I read
Who's Talking
Samuel Z Goldhaber, MD
Professor of Medicine
Harvard Medical School
Director, Venous Thromboembolism Research Group
Co-Director, Anticoagulation Management Service
Cardiovascular Division
Brigham and Women's Hospital
Boston, MA
Professor of Medicine
Harvard Medical School
Director, Venous Thromboembolism Research Group
Co-Director, Anticoagulation Management Service
Cardiovascular Division
Brigham and Women's Hospital
Boston, MA